RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy
Industry Veterans Join Team to Support the Development of Novel Cyclic Aspiration System for Ischemic StrokeMIAMI, June 23, 2021 (GLOBE...
Day: June 23, 2021
Y-mAbs Provides Regulatory Update on Omburtamab for the Treatment of Patients with Neuroblastoma
NEW YORK, June 23, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
Icario and ConnectureDRX Partner to Deliver a Seamless Enrollment Experience for Medicare Advantage Members
Integration with Icario Connect enables agents to collect valuable insights during enrollment that improve satisfaction, member experience and early risk...
SpineCraft and Wishbone Medical Enter Distribution Agreement to Increase Access to Comprehensive Spine Deformity System for Pediatric Orthopedic Market
ASTRA Deformity Spine System The comprehensive product system addresses a broad range of complex spinal pathologies with a low-profile design...
Cybin to Present at the Life Sciences Investor Forum on June 24th
TORONTO, June 23, 2021 (GLOBE NEWSWIRE) -- Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing...
Revolo Biotherapeutics Announces US FDA Approval of IND Application for Phase 2 Trial of ‘1104 in Eosinophilic Esophagitis
NEW ORLEANS and LONDON, June 23, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing...
SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)
BREXAFEMME® (ibrexafungerp tablets), for oral use A novel oral antifungal approved for the treatment of vulvovaginal candidiasis (VVC), also known...
XBiotech Announces First Patient Enrolled in Clinical Trial Evaluating XB2001 for the Treatment of Pancreatic Cancer
XB2001 Is a Novel Therapy that Interrupts Inflammation to Potentially Block Growth and Spread of Tumors and to Reduce Toxicity...
Entera Bio Announces Excellent Topline Phase 2 BMD Data for EB613, the Study Met Its Primary and Key Secondary Endpoints
Subjects receiving the 2.5 mg dose of EB613 showed significant dose-related increases in BMD at the lumbar spine, total hip,...
Clubhouse Media Signs Exclusive Management and Agency Agreement for “TheTinderBlog” to Kick Off Aggregator Account Roll-Up Strategy
The Wildly Popular Instagram Meme Account Stands to Add Nearly One Billion Monthly ImpressionsLos Angeles, June 23, 2021 (GLOBE NEWSWIRE)...
CENTR Brands Corp. Announces Sales Team Hires
Vancouver, British Columbia--(Newsfile Corp. - June 23, 2021) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company")...
Awakn Life Sciences to Commence Trading on the NEO Exchange Under the Symbol ‘AWKN’
Toronto, Ontario--(Newsfile Corp. - June 23, 2021) - Awakn Life Sciences Corp. (NEO: AWKN) ("Awakn" or the "Company") a biotechnology...
UTHealth Selects Houston-based ReMedi Health Solutions to Conduct Physician Personalization
HOUSTON--(BUSINESS WIRE)--#EHR--Houston-based IT consulting firm ReMedi Health Solutions was recently retained by The University of Texas Health Science Center at...
Outset Medical Welcomes Jean-Olivier Racine as Chief Technology Officer
Former Head of Engineering and Science for Health AI at Amazon Web Services Joins Dialysis Technology Innovation Leader SAN JOSE,...
CarePort® Introduces Care Coordination Solution for Ambulatory Providers
CarePort platform helps bridge gaps in care between ambulatory providers, patients, and home- and community-based organizations BOSTON--(BUSINESS WIRE)--CarePort, powered by...
Veradigm and PRA Health Sciences Partner to Create the Industry’s Leading EHR-Based Clinical Research Network
Through this strategic partnership, the network aims to reach more than 25,000 physicians and 40 million patients, accelerating trial recruitment...
WestPark Capital Hiring Momentum Accelerates with Four Key Additions to Its Technology Research Team
LOS ANGELES--(BUSINESS WIRE)--WestPark Capital, a full-service investment bank and broker-dealer, announced the hiring four key additions to its technology research...
Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System
Largest-ever private funding round for a dialysis device company ALCESTER, England & BEVERLY, Mass.--(BUSINESS WIRE)--$Raises #245million--Quanta Dialysis Technologies Ltd (“Quanta”...
Better Plant Launches 7 New Jusu Cold-Pressed Juices
VANCOUVER, BC / ACCESSWIRE / June 23, 2021 / Better Plant Sciences Inc. (CSE:PLNT)(OTCQB:VEGGF)(FSE:YG3) ("Better Plant" or the "Company") is...
ABIVAX Reports Excellent Phase 2A Clinical Safety and Efficacy Results with 50mg ABX464 in Rheumatoid Arthritis
Primary endpoint met with ABX464 demonstrating good safety and tolerability profile with 50mg once daily oral administrationA statistically significant difference...